Cargando…

Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis

Background and Aims: Changes in gut serotonin (5-HT) content have been described in Inflammatory Bowel Disease (IBD) and in different experimental models of colitis: the critical role of this monoamine in the pathogenesis of chronic gastrointestinal inflammation is gradually emerging. Aim of the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapalli, Alberto, Bertoni, Simona, Arcaro, Valentina, Saccani, Francesca, Grandi, Andrea, Vivo, Valentina, Cantoni, Anna M., Barocelli, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802166/
https://www.ncbi.nlm.nih.gov/pubmed/27047383
http://dx.doi.org/10.3389/fphar.2016.00068
_version_ 1782422680702550016
author Rapalli, Alberto
Bertoni, Simona
Arcaro, Valentina
Saccani, Francesca
Grandi, Andrea
Vivo, Valentina
Cantoni, Anna M.
Barocelli, Elisabetta
author_facet Rapalli, Alberto
Bertoni, Simona
Arcaro, Valentina
Saccani, Francesca
Grandi, Andrea
Vivo, Valentina
Cantoni, Anna M.
Barocelli, Elisabetta
author_sort Rapalli, Alberto
collection PubMed
description Background and Aims: Changes in gut serotonin (5-HT) content have been described in Inflammatory Bowel Disease (IBD) and in different experimental models of colitis: the critical role of this monoamine in the pathogenesis of chronic gastrointestinal inflammation is gradually emerging. Aim of the present study was to evaluate the contribution of endogenous 5-HT through the activation of its specific receptor subtypes to the local and systemic inflammatory responses in an experimental model of IBD. Materials and Methods: Colitis was induced by intrarectal 2,4,6-TriNitroBenzene Sulfonic acid in mice subacutely treated with selective antagonists of 5-HT(1A) (WAY100135), 5-HT(2A) (Ketanserin), 5-HT(3) (Ondansetron), 5-HT(4) (GR125487), 5-HT(7) (SB269970) receptors and with 5-HT(1A) agonist 8-Hydroxy-2-(di-n-propylamino)tetralin. Results: Blockade of 5-HT(1A) receptors worsened TNBS-induced local and systemic neutrophil recruitment while 5-HT(1A) agonist delayed and mitigated the severity of colitis, counteracting the increase in colonic 5-HT content. On the contrary, blockade of 5-HT(2A) receptors improved global health conditions, reduced colonic morphological alterations, down-regulated neutrophil recruitment, inflammatory cytokines levels and colonic apoptosis. Antagonism of 5-HT(3), 5-HT(4), and 5-HT(7) receptor sites did not remarkably affect the progression and outcome of the pathology or only slightly improved it. Conclusion: The prevailing deleterious contribution given by endogenous 5-HT to inflammation in TNBS-induced colitis is seemingly mediated by 5-HT(2A) and, to a lesser extent, by 5-HT(4) receptors and coexists with the weak beneficial effect elicited by 5-HT(1A) stimulation. These findings suggest how only a selective interference with 5-HT pro-inflammatory actions may represent an additional potential therapeutic option for intestinal inflammatory disorders.
format Online
Article
Text
id pubmed-4802166
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-48021662016-04-04 Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis Rapalli, Alberto Bertoni, Simona Arcaro, Valentina Saccani, Francesca Grandi, Andrea Vivo, Valentina Cantoni, Anna M. Barocelli, Elisabetta Front Pharmacol Pharmacology Background and Aims: Changes in gut serotonin (5-HT) content have been described in Inflammatory Bowel Disease (IBD) and in different experimental models of colitis: the critical role of this monoamine in the pathogenesis of chronic gastrointestinal inflammation is gradually emerging. Aim of the present study was to evaluate the contribution of endogenous 5-HT through the activation of its specific receptor subtypes to the local and systemic inflammatory responses in an experimental model of IBD. Materials and Methods: Colitis was induced by intrarectal 2,4,6-TriNitroBenzene Sulfonic acid in mice subacutely treated with selective antagonists of 5-HT(1A) (WAY100135), 5-HT(2A) (Ketanserin), 5-HT(3) (Ondansetron), 5-HT(4) (GR125487), 5-HT(7) (SB269970) receptors and with 5-HT(1A) agonist 8-Hydroxy-2-(di-n-propylamino)tetralin. Results: Blockade of 5-HT(1A) receptors worsened TNBS-induced local and systemic neutrophil recruitment while 5-HT(1A) agonist delayed and mitigated the severity of colitis, counteracting the increase in colonic 5-HT content. On the contrary, blockade of 5-HT(2A) receptors improved global health conditions, reduced colonic morphological alterations, down-regulated neutrophil recruitment, inflammatory cytokines levels and colonic apoptosis. Antagonism of 5-HT(3), 5-HT(4), and 5-HT(7) receptor sites did not remarkably affect the progression and outcome of the pathology or only slightly improved it. Conclusion: The prevailing deleterious contribution given by endogenous 5-HT to inflammation in TNBS-induced colitis is seemingly mediated by 5-HT(2A) and, to a lesser extent, by 5-HT(4) receptors and coexists with the weak beneficial effect elicited by 5-HT(1A) stimulation. These findings suggest how only a selective interference with 5-HT pro-inflammatory actions may represent an additional potential therapeutic option for intestinal inflammatory disorders. Frontiers Media S.A. 2016-03-22 /pmc/articles/PMC4802166/ /pubmed/27047383 http://dx.doi.org/10.3389/fphar.2016.00068 Text en Copyright © 2016 Rapalli, Bertoni, Arcaro, Saccani, Grandi, Vivo, Cantoni and Barocelli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rapalli, Alberto
Bertoni, Simona
Arcaro, Valentina
Saccani, Francesca
Grandi, Andrea
Vivo, Valentina
Cantoni, Anna M.
Barocelli, Elisabetta
Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title_full Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title_fullStr Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title_full_unstemmed Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title_short Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis
title_sort dual role of endogenous serotonin in 2,4,6-trinitrobenzene sulfonic acid-induced colitis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802166/
https://www.ncbi.nlm.nih.gov/pubmed/27047383
http://dx.doi.org/10.3389/fphar.2016.00068
work_keys_str_mv AT rapallialberto dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT bertonisimona dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT arcarovalentina dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT saccanifrancesca dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT grandiandrea dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT vivovalentina dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT cantoniannam dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis
AT barocellielisabetta dualroleofendogenousserotoninin246trinitrobenzenesulfonicacidinducedcolitis